Pharming Group to Attend Oppenheimer Conference
Pharming Group N.V. announces its participation in the 36th annual Oppenheimer Healthcare Life Sciences Conference, which will be held virtually on February 25 and 26, 2026. The company's CEO and Chief Medical Officer will present the company's work.
Participation Details
Pharming Group will take part in the 36th annual Oppenheimer Healthcare Life Sciences Conference, scheduled virtually on February 25 and 26, 2026. Fabrice Chouraqui, Chief Executive Officer, and Anurag Relan, Chief Medical Officer, will present the company's activities on Wednesday, February 25 at 12:40 PM Eastern Standard Time / 6:40 PM Central European Time. A live broadcast and a recording of the presentation will be available in the 'Upcoming Events' and 'News' sections of Pharming's website.
Investor Meetings
Investors wishing to arrange a one-on-one meeting with Pharming's management team can contact their Oppenheimer representative. The company is a global biopharmaceutical enterprise based in Leiden, the Netherlands, dedicated to developing and marketing innovative medicines for patients suffering from rare, debilitating, and potentially life-threatening diseases.
